Quantcast
Last updated on April 24, 2014 at 6:16 EDT

Latest balloon catheter Stories

2009-03-10 08:02:00

Latest Innovation in Balloon Technology, Designed to Optimize Treatment of Patients with Coronary Artery Disease ABBOTT PARK, Ill., March 10 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced the launch of VOYAGER(TM) NC Coronary Dilatation Catheter, a next-generation balloon dilatation catheter with high-pressure capability designed to optimize the treatment of patients with coronary artery disease (CAD) during angioplasty procedures. VOYAGER NC is now available in the United...

2009-03-03 06:00:00

BURLINGTON, Mass., Mar. 3 /PRNewswire/ -- CorNova, Inc. today announced the addition of Andrew T. Jay, D.M.D., to its board of directors. The addition increases board membership to 4. (Logo: http://www.newscom.com/cgi-bin/prnh/20070206/CLTU213LOGO ) Dr. Jay, 46, is the managing partner of the Medical Solutions Fund of Siemens Venture Capital GmbH, the venture organization for Siemens AG. Prior to joining Siemens Venture Capital, he was an Institutional Investor-ranked medical technology...

2009-02-17 06:00:00

Company Also Names Richard Sahagian as Senior Scientist BURLINGTON, Mass., Feb. 17 /PRNewswire/ -- CorNova(R), Inc. today announced the expansion of its executive team with the appointment of Robert Gallahue as chief financial officer. The company also announced the addition of Richard Sahagian as senior scientist. (Logo: http://www.newscom.com/cgi-bin/prnh/20070206/CLTU213LOGO ) The appointments reflect the evolution of the company's endovascular product line, which includes the...

2008-12-09 15:30:00

PLYMOUTH, Minn., Dec. 9 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV), a global endovascular device company, announced today that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) to market its EverCross 0.035" and NanoCross 0.014" peripheral angioplasty balloon catheters. ev3 expects to begin full commercialization of the EverCross and NanoCross peripheral balloon catheters globally in January 2009. Robert Palmisano, ev3's president and chief...

2008-10-07 12:00:53

An analysis of clinical data from 90 hospitals across the nation showed that during certain parts of the day, wait times for cardiac catheterization procedures significantly exceed the recommended standard of 90 minutes. The data analysis research was performed by VHA Inc., the national health care alliance. According to the American College of Cardiology and the American Heart Association, the benchmark door-to-balloon time -- the time between arrival at the hospital ED and having a...

2008-09-21 03:00:12

By Mularczyk, T Kostewicz, W Aim. Local intra-arterial thrombolysis is one of the methods of treatment of acute ischemia of extremities. Its aim is rapid restoration of arterial patency and the reperfusion of the ischemic extremity. It allows the identification of the cause of arterial occlusion. Identification and description of arterial wall lesions informs decisions optimizing further therapy, either surgical or endovascular. Methods. From 2003 to 2005, 17 patients with femoro- popliteal...

2008-07-15 15:00:53

DALLAS, July 15 /PRNewswire-USNewswire/ -- A man suffering a heart attack recently arrived at the Presbyterian Hospital of Dallas ER and was eventually treated with an angioplasty procedure in the hospital's cardiac catheterization lab in 28 minutes. The procedure, performed by Dr. Kenneth Saland, an interventional cardiologist at Presbyterian, involved using a tiny balloon to open a blocked coronary artery and illustrates the importance of providing treatments in a safe, rapid way to those...

2008-07-11 12:01:05

AngioScore has launched new longer and larger AngioSculpt percutaneous transluminal angioplasty scoring balloon catheters for the treatment of peripheral artery disease. The new devices have received the FDA 510(k) clearance to market for the dilatation of lesions in the iliac, femoral, ilio-femoral, popliteal, and infra popliteal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. The new AngioSculpt devices incorporate longer...

2008-07-10 09:01:29

AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the launch of new longer and larger AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD). The new devices have received U.S. Food and Drug Administration (FDA) 510(k) clearance to market for the dilatation of lesions in the iliac, femoral, ilio-femoral, popliteal, and infra popliteal arteries, and for the treatment of...

2008-06-27 09:03:10

MONTREAL, June 27 /PRNewswire-FirstCall/ -- CryoCath(R) Technologies Inc., the global leader in cryotherapy products to treat cardiac arrhythmias, today announced the introduction of Arctic Front(R) in Italy, Belgium and Spain. Arctic Front, the Company's lead product for the treatment of paroxysmal atrial fibrillation (PAF), is a unique cryoablation balloon catheter that allows physicians to safely and effectively isolate all four pulmonary veins for the treatment of PAF. "The introduction...


Latest balloon catheter Reference Libraries

Interventional Radiology
2013-03-04 16:18:42

Interventional radiology (IR) is a special sub-operation under general radiology. It is used to find, diagnose and treat a disease in almost every body system. The process of interventional radiology is very noninvasive to help with the recovery and outcome of the procedure. It utilizes x-rays, CT, ultrasound, MRI, and other modes of imaging in order to direct tools in the body as well as a variety of catheters, narrow tubes, so that incisions can be minimalized. How it is Performed...

More Articles (1 articles) »